type here...

CATEGORIES

Clinical Trials

LATEST

123Page 3 of 3

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Texas: Vaccine Clinical Study Participants – Men and Women

Medika Life -
Apply to Cedar Health to participate in a clinical vaccine study This study is open to healthy men and women. Vaccine safety and it's impact

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Medika Life -
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

Clinical Trials for Bacterial Vaginosis in Dallas, Forth Worth Area

Cedar Health Research -
About 1 in 10 women of reproductive age are affected by endometriosis. Local physicians at Cedar Health Research are initiating new research studies in hopes of finding potential new treatment options

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories